Nasdaq 100 52-Week Highs & Lows Radar: Electronic Arts, (EA), Lululemon Athletica inc (LULU) and more
MarketsFN Team
Nasdaq 100 52-Week Highs & Lows Radar: Electronic Arts, (EA), Lululemon Athletica inc (LULU) and more
Screening all 101 Nasdaq 100 constituents for stocks nearest to their 52-week high and their 52-week low. Data as of September 07, 2026. % Realized = 52-week total return.
Legend: RSI > 70 = overbought · RSI < 30 = oversold · Green % Realized = positive 52W return · Red = negative.
📈 Nearest to 52-Week High
Sectors represented: Healthcare (3), Communication Services (1), Technology (1)
| Ticker | Company | Sector | Price Last | % Realized | 52-Week High Date | RSI | % above MA200 | Trend |
|---|---|---|---|---|---|---|---|---|
| EA | Electronic Arts, Inc | Communication Services | $209.70 | +0.38% | 2026-08-04 | — | — | — |
| AMGN | AMGEN Inc | Healthcare | $437.23 | +54.15% | 2026-09-03 | 61.9 | +22.0% | Above MA20, MA50, MA200 |
| BIIB | Biogen Inc | Healthcare | $220.83 | +56.98% | 2026-09-03 | 58.0 | +15.6% | Above MA20, MA50, MA200 |
| VRTX | Vertex Pharmaceuticals, Inc | Healthcare | $546.12 | +37.87% | 2026-09-03 | 59.4 | +17.2% | Above MA20, MA50, MA200 |
| NVDA | NVIDIA Corp | Technology | $230.36 | +37.92% | 2026-05-14 | 60.4 | +17.1% | Above MA20, MA50, MA200 |
EA | Electronic Arts, Inc | Communication Services | Price Last: $209.70 | % Realized: +0.38% | RSI: — | % above MA200: — | Trend: —
Electronic Arts, Inc (EA) is a leading interactive entertainment software company, generating revenue primarily through game development and publishing. Investors should care about EA's ability to innovate and capture market share in the gaming industry.
The stock is near a potential breakout, 0.0% below its 52-Week high. However, with RSI(14) and MA alignment data unavailable, it's unclear if this is driven by momentum; the 0.4% 52-Week return suggests limited growth.
AMGN | AMGEN Inc | Healthcare | Price Last: $437.23 | % Realized: +54.15% | RSI: 61.9 | % above MA200: +22.0% | Trend: Above MA20, MA50, MA200
AMGEN Inc is a biotechnology company that develops and markets human therapeutics, focusing on innovative treatments for serious illnesses such as cancer, cardiovascular disease, and bone health conditions, making it an attractive investment for those seeking exposure to the biotech sector.
AMGN's current technical situation indicates sustained uptrend momentum, with RSI(14) at 61.9, price above MA20, MA50, and MA200, and is 1.6% below its 52-Week high, suggesting potential for a breakout.
Related headlines
BIIB | Biogen Inc | Healthcare | Price Last: $220.83 | % Realized: +56.98% | RSI: 58.0 | % above MA200: +15.6% | Trend: Above MA20, MA50, MA200
Biogen Inc is a biotechnology company that develops treatments for neurological diseases, such as multiple sclerosis and Alzheimer's. Investors should care because its therapies have significant market potential and the company has a history of innovation.
Biogen's current technical situation indicates sustained uptrend with price > MA20 > MA50 > MA200, RSI(14) at 58.0, and is 1.6% below its 52-Week high, suggesting momentum with potential for breakout.
Related headlines
- Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
- Stoke Therapeutics and Biogen to present four-year zorevunersen data at epilepsy congress
- Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
VRTX | Vertex Pharmaceuticals, Inc | Healthcare | Price Last: $546.12 | % Realized: +37.87% | RSI: 59.4 | % above MA200: +17.2% | Trend: Above MA20, MA50, MA200
Vertex Pharmaceuticals, Inc is a biotechnology company that develops and commercializes transformative medicines for serious diseases, notably cystic fibrosis with its flagship product Trikafta/Kaftrio, driving significant revenue growth and making it an attractive investment in the biotech sector.
Vertex Pharmaceuticals shows a bullish technical setup with RSI(14) at 59.4, indicating rising momentum, and a sustained uptrend as price ($546.12) remains above MA20 > MA50 > MA200; it's 2.1% below its 52-Week high, suggesting potential for a breakout.
Related headlines
- Vertex Completes $10 Billion Crinetics Acquisition, Adding Rare Endocrine Growth Platform
- Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team
- Vertex to Participate in Upcoming September Investor Conferences
- Vertex Stock Jumps 5.9% as Rival Cystic Fibrosis Drug Fails
NVDA | NVIDIA Corp | Technology | Price Last: $230.36 | % Realized: +37.92% | RSI: 60.4 | % above MA200: +17.1% | Trend: Above MA20, MA50, MA200
NVIDIA Corp is a leader in GPU technology and AI computing, driving growth in gaming, professional visualization, datacenter, and automotive markets. Investors care due to its dominance in high-growth sectors and expanding ecosystem.
NVIDIA Corp is in a sustained uptrend with price > MA20 > MA50 > MA200, RSI(14) at 60.4, and is 2.3% below its 52-Week high, indicating strong momentum with potential for breakout.
Related headlines
📉 Nearest to 52-Week Low
Sectors represented: Consumer Cyclical (1), Communication Services (1), Healthcare (1), Consumer Defensive (1), Utilities (1)
| Ticker | Company | Sector | Price Last | % Realized | 52-Week Low Date | RSI | % above MA200 | Trend |
|---|---|---|---|---|---|---|---|---|
| LULU | Lululemon Athletica inc | Consumer Cyclical | $100.61 | -40.04% | 2026-09-04 | 31.8 | -34.1% | Below MA20, MA50, MA200 |
| EA | Electronic Arts, Inc | Communication Services | $209.70 | +0.38% | 2026-07-17 | — | — | — |
| IDXX | Idexx Laboratories, Inc | Healthcare | $535.38 | -16.74% | 2026-06-30 | 41.4 | -11.8% | Below MA20, MA50, MA200 |
| PEP | PepsiCo Inc | Consumer Defensive | $137.63 | -5.98% | 2026-07-23 | 42.0 | -7.5% | Below MA20, MA50, MA200 |
| EXC | Exelon Corp | Utilities | $43.64 | +0.48% | 2025-09-16 | 38.5 | -5.0% | Below MA20, MA50, MA200 |
LULU | Lululemon Athletica inc | Consumer Cyclical | Price Last: $100.61 | % Realized: -40.04% | RSI: 31.8 | % above MA200: -34.1% | Trend: Below MA20, MA50, MA200
Lululemon Athletica inc designs and sells athletic wear, particularly yoga and running apparel. Investors care due to its strong brand loyalty and premium pricing, which drive revenue growth and profitability in the competitive athleisure market.
Lululemon's technicals indicate a warning sign: RSI(14) is 31.8, below MA20/MA50/MA200 with mixed signals, and the stock is 0.0% above its 52-Week low, having lost 40.0% over the 52-Week period, testing major support.
Related headlines
EA | Electronic Arts, Inc | Communication Services | Price Last: $209.70 | % Realized: +0.38% | RSI: — | % above MA200: — | Trend: —
Electronic Arts, Inc (EA) is a leading interactive entertainment software company, generating revenue primarily through game development and publishing. Investors should care about EA's ability to innovate and capture market share in the gaming industry.
The stock is near a potential breakout, 0.0% below its 52-Week high. However, with RSI(14) and MA alignment data unavailable, it's unclear if this is driven by momentum; the 0.4% 52-Week return suggests limited growth.
IDXX | Idexx Laboratories, Inc | Healthcare | Price Last: $535.38 | % Realized: -16.74% | RSI: 41.4 | % above MA200: -11.8% | Trend: Below MA20, MA50, MA200
Idexx Laboratories, Inc is a veterinary diagnostics company providing testing solutions and services. Investors should care because its products and services are crucial for animal health, driving revenue growth and profitability.
IDXX's technicals indicate a sustained downtrend with price ($535.38) below MA20, MA50, and MA200. RSI(14) is 41.4, nearing oversold territory. The stock is 1.7% above its 52-Week low, testing major support, with a -16.7% 52-Week return, signaling potential further downside.
Related headlines
- IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
- IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
- IDEXX Laboratories, Inc. Q2 2026 Earnings Call Summary
- IDEXX Laboratories Inc (IDXX) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ...
PEP | PepsiCo Inc | Consumer Defensive | Price Last: $137.63 | % Realized: -5.98% | RSI: 42.0 | % above MA200: -7.5% | Trend: Below MA20, MA50, MA200
PepsiCo Inc is a diversified food and beverage company with brands like Pepsi, Lay's, and Gatorade, generating revenue through beverage sales, snack foods, and other categories, making it a staple in consumer staples with a broad market presence.
PepsiCo's technicals indicate a warning sign with an RSI(14) of 42.0, below MA20/MA50/MA200, and only 2.0% above its 52-Week low, suggesting testing major support, and a -6.0% return over the 52-Week period, indicating bearish momentum.
Related headlines
EXC | Exelon Corp | Utilities | Price Last: $43.64 | % Realized: +0.48% | RSI: 38.5 | % above MA200: -5.0% | Trend: Below MA20, MA50, MA200
Exelon Corp (EXC) is a utility company that generates and distributes electricity, primarily through nuclear and natural gas power plants. Investors care about its stable cash flows and dividend yield, given its role in meeting energy demands.
EXC's technicals indicate a sustained downtrend with price ($43.64) below MA20, MA50, and MA200. RSI(14) is 38.5, nearing oversold territory. The stock is 2.1% above its 52-Week low, testing major support, with a 0.5% return over the 52-Week period.
Related headlines
- Exelon Announces Key Leadership Position Changes
- Exelon Secures More Than $1 Billion in Customer Protections Through Pioneering Transmission Security Agreements
- Exelon high probability data center load falls 40%
- Exelon Corp (EXC) (Q2 2026) Earnings Call Highlights: Navigating Regulatory Hurdles and Data ...
Market Commentary
The Nasdaq 100 stocks listed near 52-week extremes indicate a significant trend in the technology sector. Stocks near 52-week highs, such as NVDA (-2.3% from 52W high) and VRTX (-2.1% from 52W high), suggest a strong uptrend, while those near 52-week lows, like LULU (+0.0% above 52W low) and EA (+0.4% above 52W low), may be experiencing downward pressure.
The technology sector's performance is often tied to broader macroeconomic themes. The presence of pharmaceutical stocks like AMGN (-1.6% from 52W high) and BIIB (-1.6% from 52W high) near 52-week highs may indicate investor confidence in the sector's growth prospects. Conversely, the presence of consumer staples like PEP (+2.0% above 52W low) near 52-week lows could be related to concerns about consumer demand.
Key levels to watch include the 52-week extremes for these stocks. A breakout above the 52-week high for NVDA, VRTX, or AMGN could signal further upside, while a breakdown below the 52-week low for LULU or EA may indicate continued weakness. Investors should monitor these levels and be aware of potential catalysts, such as earnings reports or macroeconomic announcements, that could drive price movements.
Methodology: All 101 Nasdaq 100 constituents screened. 52-week high = highest daily close over the past 252 trading days (approx. 1 year). 52-week low = lowest daily close over the same period. Distance = (current price / extreme − 1) × 100. Technical indicators computed on up to 1 year of daily OHLCV data.
Disclaimer: For informational purposes only. Not investment advice. Past performance is not indicative of future results.
